ResearcherTianjin Medical University General HospitalActive in the last 2 years

Xuezhi Du

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6872-3115; OpenAlex author ID A5017192367. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 1 paper

Papers 1

USP10 promotes the progression and attenuates gemcitabine chemotherapy sensitivity via stabilizing PLK1 in PDAC. Co-author DOI 10.1038/s41419-025-07757-z ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yaqing Wei · 1 shared paper, 2025 · strength 0.24
- Paper USP10 promotes the progression and attenuates gemcitabine chemotherapy sensitivity via stabilizing PLK1 in PDAC. DOI 10.1038/s41419-025-07757-z ↗
Chenhui Zhang · 1 shared paper, 2025 · strength 0.24
- Paper USP10 promotes the progression and attenuates gemcitabine chemotherapy sensitivity via stabilizing PLK1 in PDAC. DOI 10.1038/s41419-025-07757-z ↗
Jinjin Sun · 1 shared paper, 2025 · strength 0.24
- Paper USP10 promotes the progression and attenuates gemcitabine chemotherapy sensitivity via stabilizing PLK1 in PDAC. DOI 10.1038/s41419-025-07757-z ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.